Gilead Sciences Inc et al v Khaim et al No 12024cv04259
Novel OnceWeekly HIV Treatment with Islatravir and Lenacapavir Shows
GILEAD SCIENCES INC v USA No 12020cv00499 Justia Law
Gilead Sciences Inc et al v Khaim et al No 12024cv04259
No 1 at 1315 Gileads portfolio includes drugs for the treatment or prevention of HIV which bear certain established trademarks denoting authenticity Id Following the receipt of multiple complaints from patients and pharmacies who had purchased Gileadbranded products from a pharmaceutical distributor
Gilead Scis Inc No 1192103 D Del June 20 2023 ECF No 488 In the Delaware case should the governments motion for a new trial be successful and the outcome of that new trial be contrary to the current verdict Gileads equitable defenses would almost certainly be reached Although this outcome is a possibility it is not one
Sacituzumab govitecan withdrawn from bladder cancer market following
The government notified Gilead on March 11 2016 that Truvada may be covered by patents recently obtained by CDC First Am Compl Ex 26 Mar 11 2016 correspondence at 1 ECF No 34267 Gilead countered that the government had breached their agreements and that the patents were not valid First Am Compl 110
No 1 Gila4d2
In the United States Court of Federal Claims
The Barrons 500 An Exclusive Ranking Barrons
No 1 at 1315 Gileads portfolio includes drugs for the treatment or prevention of HIV which bear certain established trademarks denoting authenticity Id Following the receipt of multiple complaints from patients and pharmacies who had purchased Gileadbranded products from a pharmaceutical distributor id at 7375
See Dkt No 22 at 34 1 On June 18 2024 the Court granted Gileads proposed seizure order and permitted inter alia Gileads agents to search seize copy and sequester items in the possession custody or control of Mr Khaim including electronic records and the cellular or smart phones used by Mr Khaim
In the United States Court of Federal Claims
Gilead alleges that Defendants sold authenticlooking Gileadbranded bottles repurposed with nonGilead drugs such as antipsychotic medication that do not treat HIV Dkt No 1 at 78 7677 Gilead also alleges that defendants sold thousands of Gileadbranded 12 bottles with the correct Gilead medication but accompanied by fake
No 1 Gila4d2
Gilead has voluntarily withdrawn the US indication of sacituzumab govitecanhziy Trodelvy for adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinumcontaining chemotherapy and either a PD1 or PDL1 inhibitor the company announced in a news release 1
Gilead Sciences Inc et al v Khaim et al No 12024cv04259
Gilead Scis v Khaim No 24CV4259 EDNY CaseMine
alleges in the Delaware lawsuit that Gilead infringed its patents by selling and promoting Truvada and a related drug Descovy for HIV PrEP First Am Compl 115 On April 24 2020 Gilead filed suit in this court alleging breach of the MTAs and CTAs See Compl ECF No 1 The government then moved to dismiss pursuant to Rules 12b1 and
Gilead Sciences is No 1 in our exclusive annual ranking of companies with superior operating performance with CBRE at No 2
The novel combination of islatravir Merck and lenacapavir Gilead maintained high rates of viral suppression in virologically suppressed adults with HIV after 48 weeks of treatment according to the results of a Phase II clinical trial NCT05052996 presented during at ID Week 2024 12 Trial investigators noted that these findings could lead to the combination therapy becoming the first